AvKARE
-
Drug News
AvKARE, LLC. Issues Voluntary Nationwide Recall of Atovaquone Oral Suspension Due to Potential Contamination: What Consumers Need to Know
AvKARE, LLC has initiated a voluntary recall of Atovaquone Oral Suspension, USP 750 mg/5 mL, lot # AW0221A, due to…
Read More »